Clover Health Investments Corp reported strong growth in Medicare Advantage membership of over 50% in 2025, driven by the proprietary Clover Assistant platform’s physician enablement and open network model. Despite this revenue increase to nearly $1.9 billion from insurance premiums in 2025, the company remains unprofitable with an operating loss of approximately $85 million and negative operating cash flow. Regulatory scrutiny, including CMS Star rating reductions for PPO plans affecting future reimbursements, poses ongoing risks. Capital allocation has included moderate share repurchases, but cash flow deficits persist. The company’s proprietary technology and open network differentiate it amid intense competition from large insurers, though profitability hurdles and regulatory compliance remain key challenges.